Captrust Financial Advisors Kymera Therapeutics, Inc. Transaction History

Captrust Financial Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$14.13 - $42.55 $28 - $85	-2 Reduced 1.47%	134 $3,000
Q1 2022 May 16, 2022	BUY	$35.3 - $64.68 $4,800 - $8,796	136 New	136 $6,000
Q2 2021 Aug 16, 2021	SELL	$31.08 - $51.95 $217 - $363	-7 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$35.64 - $85.46 $249 - $598	7 New	7 $0

186

65.5M

49.6K

17K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.01B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.